SCN2A and pulmonary arterial hypertension: Pathogenically, SCN2A variants alter voltage-gated sodium channel activity, leading to early infantile epileptic encephalopathy, whereas PAH and GNPAT variants disrupt amino acid and peroxisomal metabolism, respectively.